May 9, 20244FMC GlobalSat’s Acquisition of Anuvu’s Maritime, Energy and Government Connectivity Businesses
April 29, 20244Abu Dhabi National Insurance Company’s Acquisition of Shares in Allianz Saudi Fransi Cooperative Insurance
May 10, 20244Mainstream Renewable Power and Revenuts Power’s 2.5GW Offshore Wind Project In Gippsland Region
May 9, 20244A&O Shearman Bolsters M&A and Real Estate With the Addition of Partners Emanuele Trucco and Andrea De Pieri in Italy
May 9, 20244Dechert Bolsters Fintech and Crypto Regulatory Expertise with Key Strategic Hire Neel Maitra
June 21, 20234Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture
June 19, 20234The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.
May 9, 20244A&O Shearman Bolsters M&A and Real Estate With the Addition of Partners Emanuele Trucco and Andrea De Pieri in Italy
May 9, 20244Dechert Bolsters Fintech and Crypto Regulatory Expertise with Key Strategic Hire Neel Maitra
Homepage North America North America Legal Chronicle Royalty Pharma’s $1.5 Billion Acquisition of PTC Therapeutics’ Royalties Royalty Pharma’s $1.5 Billion Acquisition of PTC Therapeutics’ Royalties October 30, 2023 Leila Ahmed Tagged: 10-30-2023 Barry Bazian Carl Morales Catherine Magazu Elliot Horlick Emily Powers Fenwick & West LLP George Shuster Jr Goodwin Procter Jacqueline Mercier Kristopher Ring megadeals Nathan Moore PTC Therapeutics Robert Crawford Royalty Pharma William Ogden Wilmer Cutler Pickering Hale and Dorr Zhe Yang Fenwick & West, Goodwin Procter and Maiwald represented Royalty Pharma in the transaction, Wilmer Cutler Pickering Hale and Dorr represented PTC Therapeutics.Royalty Pharma plc (Nasdaq: RPRX)… This content is for Standard 1 Year members only.Login Join Now